U.S. health officials on Friday approved the first nasal spray to treat severe allergic reactions, offering an alternative to injectable products like EpiPen.

The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis. The spray is intended for people who weigh at least 66 pounds.

The spray is one of several needle-free devices being developed to treat between 33 million and 45 million Americans with severe allergies to food and other triggers{ai:summary}<p>In a world where allergies can strike like a thief in the night, U.S. health officials now offer a nasal spray to combat anaphylactic shocks, a sleek alternative to the old trusty EpiPen. This new weapon in the medical arsenal targets those who tip the scales at 66 pounds or more.</p><p>It's a lifeline for adults and older kids, a puff of hope when the air gets thick with danger. The FDA has clenched its stamp of approval, aiming to change the game for those caught in allergic ambushes. #health</p>

FDA approves a nasal spray that treats severe allergic reactions

Loading...